| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.068 | 19.196 | 17.148 | 3.266 | 517 | 2.022 | 7.097 | 0 | 0 |
| Total Income - EUR | - | 6.068 | 19.197 | 17.152 | 4.345 | 517 | 2.022 | 7.099 | 0 | 0 |
| Total Expenses - EUR | - | 3.258 | 13.574 | 15.485 | 4.249 | 172 | 358 | 281 | 22 | 25 |
| Gross Profit/Loss - EUR | - | 2.810 | 5.623 | 1.666 | 96 | 346 | 1.664 | 6.818 | -22 | -25 |
| Net Profit/Loss - EUR | - | 2.628 | 5.348 | 1.495 | -9 | 331 | 1.603 | 6.605 | -22 | -25 |
| Employees | - | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Mexa Consulting S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 815 | 400 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 2.497 | 7.941 | 9.733 | 4.955 | 5.157 | 6.709 | 6.783 | 2.798 | 44 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 401 | 657 | 0 | 0 | 0 | 0 | 0 | 49 | 0 |
| Cash | - | 2.096 | 7.284 | 9.733 | 4.955 | 5.157 | 6.709 | 6.783 | 2.750 | 44 |
| Shareholders Funds | - | 2.672 | 7.975 | 9.324 | 4.920 | 5.157 | 6.646 | 6.783 | 2.798 | 23 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 640 | 377 | 451 | 35 | 0 | 63 | 0 | 0 | 21 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Dr. Mexa Consulting S.r.l.